Brief report · 29 Dec 2025
Conference abstractPublished 1 Oct 2012
Younger is better: Old stem cells aren’t what they used to be
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T he idea of stem cells as medical therapy has become almost commonplace. Millions of individuals have stored stem cells in biobanks for future use, and tens of thousands of have received stem cell transplants or infusions for regenerative medicine therapies. But often overlooked are everyday factors that may impair the utility of these stem cells, including stem cell age and donor health. There is increasing evidence that both factors can significantly impact the therapeutic potential of stem cells. The hematopoietic stem cell is the best characterized of all stem cells. Weissman and others have shown significant functional changes with age, a finding confirmed upon analysis of cord blood transplant recipients. Similar findings have also been observed with neural stem cells.In terms of regenerative medicine, many are looking at mesenchymal stem cells (MSC). Numerous studies have indicated that MSCs isolated from older donors, as well as from patients with chronic disease conditions, are neither as prevalent (in terms of the number of cells in the sample) nor as potent as those isolated from younger, healthier donors.MSCs collected from olderdonors seem less able to differentiate into the different cell types needed for tissue engineering, slower to proliferate and expand to numbers of cells that would allow for multiple treatments, and more prone to dying during culture and use. Evidence that MSC quality declines with donor age warrants concern for cell based therapies. The ability of older stem cells to respond to injury may be compromised and could contribute to inferior tissue repair. We have observed such results when analyzing the effects of stem cell age in a chronic wound model.In addition, Shenet al at the University of Texas-Arlingtonfound that aging female mice transplanted with young MSCs had prolonged life span (by 15-20%). In contrast, older MSCs failed to prolong life span at all. Thus, it seems that stem cells, like the rest of the cells in our bodies, also suffer from the ravages of time. Stemcells (of various types) collected from younger, healthier donorsare more effective for transplantation and regenerative medicine than those collected from older individuals, which makes a strong case for the preservation of stem cells at the earliest possible time, and for the consideration of donor age when transplanting stem cells.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Tissue Science and Engineering.
Opinion · 29 Dec 2025
Biomaterials, Cells, And Stimulation For Spinal Cord Repair
Brief report · 29 Dec 2025
Cardiac Tissue Engineering: Building a New Heart
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Tissue Science and Engineering
- SubjectEngineering
- BylineArticles whose byline prints “David T Harris”
